Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 2,467 | 1,756 | 1,264 | 1,143 | 1,026 |
| Operating Income | -2,467 | -1,756 | -1,264 | -1,143 | -1,026 |
| Other Income | 74 | 92 | 120 | 106 | 23 |
| Pre-tax Income | -2,393 | -1,663 | -1,144 | -1,037 | -1,003 |
| Net Income Continuous | -2,393 | -1,663 | -1,144 | -1,037 | -1,003 |
| Net Income | $-2,393 | $-1,663 | $-1,144 | $-1,037 | $-1,003 |
| EPS Basic Total Ops | -2.24 | -1.56 | 0.27 | -1.01 | -1.35 |
| EPS Basic Continuous Ops | -2.24 | -1.56 | 0.20 | -1.01 | -1.28 |
| EPS Diluted Total Ops | -2.24 | -1.56 | 0.27 | -1.01 | -1.35 |
| EPS Diluted Continuous Ops | -2.24 | -1.56 | 0.20 | -1.01 | -1.28 |
| EPS Diluted Before Non-Recurring Items | -2.25 | -1.50 | -0.75 | N/A | N/A |
| EBITDA(a) | $-2,466 | $-1,755 | $-1,263 | $-1,142 | $-1,026 |